December 2026
1. CHEN S, Hoang MH, Hu D, He Q, et al
   Gut microbiota in early and established stages of rheumatoid arthritis: from pathogenesis to promising prevention and treatment.
   Ann Med. 2026;58:2613484.
   

   >> Share

   
   
2. LIN Y, Ou Y, Su J, Xu J, et al
   JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17/Treg imbalance in a Sjogren's disease murine model.
   Ann Med. 2026;58:2625552.
   

   >> Share

   
   
3. ZHANG X, Li J, Tan X, Wei Z, et al
   Combined diagnostic value of rheumatoid arthritis-specific citrullinated protein, haemoglobin-to-red cell distribution width ratio, and anti-CCP antibody in rheumatoid arthritis.
   Ann Med. 2026;58:2634440.
   

   >> Share

   
   December 2025
4. TSAI JJ, Liu LT, Liao PL, Wei JC, et al
   Comparative outcomes of COVID-19 in patients with primary Sjogren's syndrome treated with hydroxychloroquine versus methotrexate: a retrospective cohort study.
   Ann Med. 2025;57:2527361.
   

   >> Share

   
   
5. MANGONI AA, Wiese MD, Woodman RJ, Sotgia S, et al
   A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis.
   Ann Med. 2025;57:2539311.
   

   >> Share

   
   
6. CAI X, Yao Y
   Epigenetic modifications of immune cells in rheumatoid arthritis.
   Ann Med. 2025;57:2533432.
   

   >> Share

   
   
7. LI Y, An M, Yao L, Lu J, et al
   iTr35 cells: a novel immunoregulatory subset involved in bone loss in rheumatoid arthritis and clinical implications.
   Ann Med. 2025;57:2565438.
   

   >> Share

   
   
8. LI LM, Lv SC
   Letter to the editor regarding 'iTr35 cells: a novel immunoregulatory subset involved in bone loss in rheumatoid arthritis and clinical implications'.
   Ann Med. 2025;57:2572312.
   

   >> Share

   
   
9. GOU X, Jiao W, Chen H, Tan Y, et al
   A clinically applicable method for early interstitial lung disease detection in incident rheumatoid arthritis cases: integration of protein biomarkers and clinical factors.
   Ann Med. 2025;57:2576636.
   

   >> Share

   
   
10. LI Y, An M, Yao L, Lu J, et al
    Response to letter regarding iTr35 cells a novel immunoregulatory subset involved in bone loss in rheumatoid arthritis and clinical implications.
    Ann Med. 2025;57:2594351.
    

    >> Share

    
    
11. WANG F, Liu J, Wen J, Sun Y, et al
    Exploring the ubiquitination regulatory network: opening new perspectives for rheumatoid arthritis therapy.
    Ann Med. 2025;57:2600171.
    

    >> Share

    
    December 2024
12. WANG HF, Wang YY, Li ZY, He PJ, et al
    The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Ann Med. 2024;56:2332406.
    

    >> Share

    
    
13. CHENG JH, Cai WX, Xiang XH, Zhou MY, et al
    Platelet-to-lymphocyte ratios as a haematological marker of synovitis in rheumatoid arthritis with normal acute phase reactant level.
    Ann Med. 2024;56:2346546.
    

    >> Share

    
    
14. CAI Y, Deng L, Yao J
    Analysis and identification of ferroptosis-related diagnostic markers in rheumatoid arthritis.
    Ann Med. 2024;56:2397572.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share